• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.04% Nasdaq Down 0.55%

    Vanda Pharmaceuticals, Inc. (VNDA)

    -NasdaqGM
    9.44 Down 0.53(5.31%) 3:03PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:9.97
    Open:10.02
    Bid:9.46 x 400
    Ask:9.47 x 200
    1y Target Est:22.50
    Beta:2.47
    Next Earnings Date: 6-May-15VNDA Earnings announcement
    Day's Range:9.31 - 10.08
    52wk Range:8.34 - 16.50
    Volume:596,231
    Avg Vol (3m):775,214
    Market Cap:393.11M
    P/E (ttm):17.16
    EPS (ttm):0.55
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for VNDA

    Comparison

    Symbol% ChgMkt Cap
    VNDADown 5.31%393.11M
    AZNDown 1.16%89.63B
    LLYDown 0.89%75.24B
    JNJDown 0.31%280.20B

    Key Statistics

    Forward P/E (1 yr):189.00
    P/S (ttm):8.28
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.68
    Quarterly EPS Est (Mar-15) :-0.25
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):-0.95

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback